Patents Issued in August 30, 2016
  • Patent number: 9428763
    Abstract: Nucleic acids and the encoded CER2-like polypeptides, At1g68440-like polypeptides or DEAD-box RNA helicase polypeptides are provided. A method of enhancing yield-related traits in plants by modulating expression of nucleic acids encoding CER2-like polypeptides or At1g68440-like polypeptides is provided. A method of enhancing yield-related traits in plants by reducing or substantially eliminating expression of nucleic acids encoding DEAD-box RNA helicase polypeptides and/or the activity of DEAD-box RNA helicase polypeptides in said plants is provided. Plants with modulated expression of the nucleic acids encoding CER2-like polypeptides or At1g68440-like polypeptides have enhanced yield-related traits relative to control plants. Plants with reduction or elimination of the expression of endogenous nucleic acids encoding DEAD-box RNA helicase polypeptides have enhanced yield-related traits relative to control plants.
    Type: Grant
    Filed: July 13, 2011
    Date of Patent: August 30, 2016
    Assignee: BASF Plant Science Company GmbH
    Inventors: Ana Isabel Sanz Molinero, Steven Vandenabeele
  • Patent number: 9428764
    Abstract: The materials and methods disclosed provide for polynucleotide molecules sufficiently divergent from polynucleotides naturally contained in plants, or polynucleotides previously introduced into plants as transgenes to permit trait stacking in plant breeding methods or plant transformation methods. The disclosure also provides for methods and compositions to detect the polynucleotides of the invention in plants.
    Type: Grant
    Filed: May 21, 2013
    Date of Patent: August 30, 2016
    Assignee: Monsanto Technology LLC
    Inventor: Stanislaw Flasinski
  • Patent number: 9428765
    Abstract: The present invention provides a transgenic corn event MON89034, and cells, seeds, and plants comprising DNA diagnostic for the corn event. The invention also provides compositions comprising nucleotide sequences that are diagnostic for said corn event in a sample, methods for detecting the presence of said corn event nucleotide sequences in a sample, probes and primers for use in detecting nucleotide sequences that are diagnostic for the presence of said corn event in a sample, growing the seeds of such corn event into corn plants, and breeding to produce corn plants comprising DNA diagnostic for the corn event.
    Type: Grant
    Filed: November 12, 2013
    Date of Patent: August 30, 2016
    Assignee: Monsanto Technology LLC
    Inventors: Heather M. Anderson, Jennifer R. Reyes, Jeanna R. Groat, Scott C. Johnson, Rebecca A. Kelly, John Korte, James F. Rice
  • Patent number: 9428766
    Abstract: The current invention reports a method for the recombinant production of a secreted heterologous immunoglobulin in a CHO cell comprising the following steps: i) providing a CHO cell, which is adapted to growth in suspension culture, adapted to growth in serum-free medium, mycoplasma free, and virus free, ii) providing a vector comprising a prokaryotic origin of replication, a first nucleic acid conferring resistance to a prokaryotic selection agent, a second nucleic acid encoding the heavy chain of said heterologous immunoglobulin, a third nucleic acid encoding the light chain of said heterologous immunoglobulin, a fourth nucleic acid conferring resistance to a eukaryotic selection agent, iii) transfecting said CHO cell, wherein said transfecting comprises a) transfecting said CHO cell with said vector comprising a fourth nucleic acid conferring resistance to a first eukaryotic selection agent, b) selecting a CHO cell by growth in cultivation medium containing said first eukaryotic selection agent, c) transfe
    Type: Grant
    Filed: June 2, 2014
    Date of Patent: August 30, 2016
    Assignee: HOFFMANN-LA ROCHE INC.
    Inventors: Ulrich Goepfert, Hendrik Knoetgen, Erhard Kopetzki, Anne Stern
  • Patent number: 9428767
    Abstract: The present invention provides polynucleotide vectors for high expression of heterologous genes, and methods for constructing such vectors. Some vectors further comprise novel transposons and transposases that further improve expression. Further disclosed are vectors that can be used in a gene transfer system for stably introducing nucleic acids into the DNA of a cell. The gene transfer systems can be used in methods, for example, but not limited to, gene expression, gene therapy, insertional mutagenesis, or gene discovery.
    Type: Grant
    Filed: April 9, 2015
    Date of Patent: August 30, 2016
    Assignee: DNA2.0, INC.
    Inventors: Jeremy Minshull, Mark Welch, Sridhar Govindrajan, Kate Caves
  • Patent number: 9428768
    Abstract: The present invention relates to improved methods for producing adenovirus compositions wherein host cells are grown in a bioreactor and purified by size partitioning purification to provide purified adenovirus compositions.
    Type: Grant
    Filed: October 28, 2009
    Date of Patent: August 30, 2016
    Assignee: Crucell Holland B.V.
    Inventors: Hai Pham, Shuyuan Zhang, Peter Clarke
  • Patent number: 9428769
    Abstract: A liposome comprising a region of a lipid bilayer membrane with different membrane thicknesses, wherein each lipid bilayer membrane region is composed of a different lipid, and a thick membrane side in the region of the lipid bilayer membrane is formed of lipid having a phase transition temperature higher than that of the lipid forming a thin membrane side in the region of the lipid bilayer membrane. A proteoliposome, wherein the above-described liposome includes membrane proteins. A biochip, wherein the above-described liposome or the above-described proteoliposome is spread on a substrate. The above-described biochip, wherein the substrate includes at least one kind selected from the group consisting of mica, SiO2, SiN, Au and Pt.
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: August 30, 2016
    Assignees: Nippon Telegraph and Telephone Corporation, Isis Innovation Ltd.
    Inventors: Chandra Sekar Ramanujan, Nahoko Kasai, Keiichi Torimitsu, John F. Ryan
  • Patent number: 9428770
    Abstract: The invention provides a general and facile method to obtain secondary metabolites from fungal sources. The invention is based on the discovery that the fungal gene veA and protein encoded thereby regulates the activity of multiple secondary metabolite gene clusters in fungi. Over expression of the gene veA provides increased production of secondary metabolites in engineered cells. In particular, such a method of increasing secondary metabolite production allows the production of improved yields of valuable secondary metabolite products.
    Type: Grant
    Filed: September 15, 2014
    Date of Patent: August 30, 2016
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Nancy P. Keller, Saori Amaike Campen
  • Patent number: 9428771
    Abstract: A method is described for the oxidation of organic compounds in which the organic compound that is to be oxidized is brought to reaction in an aqueous solution in the presence of cytochrome P 450, and wherein perfluorinated organic compound is added to the aqueous reaction mixture as activator.
    Type: Grant
    Filed: September 6, 2011
    Date of Patent: August 30, 2016
    Assignee: STUDIENGESELLSCHAFT KOHLE MBH
    Inventors: Manfred T. Reetz, Felipe Emilio Zilly Claude
  • Patent number: 9428772
    Abstract: A method for producing fermentation products from lignocellulosic biomass is provided. Lignocellulosic biomass is composed of lignocellulosic fibers which are hollow and primarily contain cellulose, hemicellulose and lignin. Lignin is concentrated in the outer fiber wall and glues the fibers into bundles, but the inner fiber wall has a much lower concentration of lignin and has more easily accessible cellulose and hemicellulose. This method uses vacuum infusion to infuse enzymes into the lumen (hollow center) of lignocellulosic fibers to hydrolyze the hemicellulose and cellulose to produce sugars and oligomers, and then uses cycles of vacuum pressure to pump these homogeneous reagents and sugars and oligomers into and out of the lumen. These reagents are homogenized by mixing the reagents with process water using turbulent mixing to produce a homogeneous reagent. The sugars may be fermented, such as with yeast, to a fermentation product, such as ethanol or butanol.
    Type: Grant
    Filed: October 27, 2015
    Date of Patent: August 30, 2016
    Inventor: Edward Brian Hamrick
  • Patent number: 9428773
    Abstract: The present disclosure provides recombinant cyanobacteria having acetolactate synthase activity and acetolactate decarboxylase activity, as well as recombinant cyanobacteria having acetolactate synthase activity, acetolactate decarboxylase activity, and secondary alcohol dehydrogenase activity. Methods for the production of the recombinant cyanobacteria, as well as methods for use thereof for production of acetoin and 2,3-butanediol from carbon dioxide and light are also provided.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: August 30, 2016
    Assignee: The Regents of the University of California
    Inventors: Shota Atsumi, John W. K. Oliver, Iara M. P. Machado
  • Patent number: 9428774
    Abstract: The present invention relates to a mutant microorganism, which is selected from the group consisting of genus Mannheimia, genus Actinobacillus and genus Anaerobiospirillum, producing homo-succinic acid and a method for producing homo-succinic acid using the same, and more particularly to a mutant microorganism producing succinic acid at a high concentration while producing little or no other organic acids in anaerobic conditions, which is obtained by disrupting a gene encoding lactate dehydrogenase (ldhA), a gene encoding phosphotransacetylase (pta), and a gene encoding acetate kinase (ackA), without disrupting a gene encoding pyruvate formate lyase (pfl), as well as a method for producing succinic acid using the same. The inventive mutant microorganism has the property of having a high growth rate and succinic acid productivity while producing little or no organic acids, as compared to the prior strains producing succinic acid.
    Type: Grant
    Filed: October 3, 2015
    Date of Patent: August 30, 2016
    Assignee: KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Sang Yup Lee, Sung Won Lim, Hyohak Song
  • Patent number: 9428775
    Abstract: Disclosed is the biological production of lactic acid using a microorganism. A transformant capable of producing lactic acid of high optical purity at high yield, a method for the preparation thereof, and a method for producing lactic acid in a convenient and economically beneficial manner using the same are provided. The Zymomonas mobilis transformant can produce lactic acid of high optical purity at high yield without a stringent limitation to production conditions and a regulation of the intracellular metabolism pathway. Because it requires no additional separation and purification steps, the use of the transformant allows the production of lactic acid in a short process, resulting in a significant reduction in production cost, and avoiding the environment problems caused by precipitate wastes, which brings about environmental issues.
    Type: Grant
    Filed: February 23, 2011
    Date of Patent: August 30, 2016
    Assignee: Macrogen Inc.
    Inventors: Jae-Young Kim, Sang-Heum Shin, Hyon-Yong Chong, Kap-Seok Yang, Jeong-Sun Seo
  • Patent number: 9428776
    Abstract: Specific oxygen uptake (OUR) is used as a process control parameter in fermentation processes. OUR is determined during at least the production phase of a fermentation process, and process parameters are adjusted to maintain the OUR within desired ranges. The invention is particularly applicable when the fermentation is conducted using a microorganism having a natural PDC pathway that has been disrupted so that it no longer functions. Microorganisms of this sort often produce poorly under strictly anaerobic conditions. Microaeration controlled by monitoring OUR allows the performance of the microorganism to be optimized.
    Type: Grant
    Filed: September 6, 2014
    Date of Patent: August 30, 2016
    Assignee: Cargill Incorporated
    Inventors: Pim Van Hoek, Aristos Aristidou, Brian J. Rush
  • Patent number: 9428777
    Abstract: Objects of the present invention are to provide a transformant which can produce lactic acid with high productivity without requiring neutralization with an alkali, a method for producing the same, and a method for producing lactic acid by using the transformant. Namely, they are a transformant, in which Schizosaccharomyces pombe is used as a host, a lactate dehydrogenase gene of Lactobacillus pentosus is introduced, and a part of a gene cluster encoding a pyruvate decarboxylase in the Schizosaccharomyces pombe host is deleted or inactivated; a method for producing the transformant; and a method for producing lactic acid by using the transformant.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: August 30, 2016
    Assignee: ASAHI GLASS COMPANY, LIMITED
    Inventors: Futoshi Hara, Shuichiro Kimura
  • Patent number: 9428778
    Abstract: This invention relates to metabolically engineered microorganism strains, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a chemical product, which includes 3-hydroxypropionic acid.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: August 30, 2016
    Assignee: Cargill, Incorporated
    Inventors: Michael D. Lynch, Ryan T. Gill, Tanya E.W. Lipscomb
  • Patent number: 9428779
    Abstract: The present disclosure provides novel proteins that when over expressed in algae result in an increase or change in fatty acid and/or glycerol lipid production and/or accumulation, without a substantial decrease in the growth rate of the alga or the break down of algal components, such as chlorophyll. The present disclosure also describes methods of using the novel proteins to increase or change the production and/or accumulation of fatty acids and/or glycerol lipids in algae. In addition, these proteins are useful tools in obtaining information about the fatty acid and triacyglyceride (TAG) synthetic pathways in algae.
    Type: Grant
    Filed: February 1, 2011
    Date of Patent: August 30, 2016
    Assignee: SAPPHIRE ENERGY, INC.
    Inventors: Christopher Yohn, April Brand, Michael Mendez, Craig A. Behnke
  • Patent number: 9428780
    Abstract: The present invention relates to filamentous fungal host cells and particularly Trichoderma host cells useful for the production of heterologous granular starch hydrolyzing enzymes having glucoamylase activity (GSHE). Further the invention relates to a method for producing a glucose syrup comprising contacting a granular starch slurry obtained from a granular starch substrate simultaneously with an alpha amylase and a GSHE at a temperature equal to or below the gelatinization temperature of the granular starch to obtain a composition of a glucose syrup.
    Type: Grant
    Filed: April 16, 2015
    Date of Patent: August 30, 2016
    Assignee: Danisco US Inc.
    Inventors: Toby M. Baldwin, Benjamin S. Bower, Gopal K. Chotani, Nigel Dunn-Coleman, Oreste J. Lantero, Suzanne Lantz, Michael J. Pepsin, Jayarama K. Shetty, Bruce A. Strohm
  • Patent number: 9428781
    Abstract: One embodiment of the present invention provides for a method for amplifying a template of nucleic acid target sequence contained in a sample. The method includes contacting the sample with an amplification reaction mixture containing a primer complementary to the template of nucleic acid target sequence. A temperature of the reaction is oscillated between an upper temperature and a lower temperature wherein the change in temperature is no greater than about 20° C. during a plurality of temperature cycles. The template of nucleic acid target sequence is amplified.
    Type: Grant
    Filed: April 20, 2012
    Date of Patent: August 30, 2016
    Assignee: Mesa Biotech, Inc.
    Inventors: Hong Cai, Nathan J. Cobb
  • Patent number: 9428782
    Abstract: Disclosed are DNA polymerases having increased reverse transcriptase efficiency relative to a corresponding, unmodified polymerase. The polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the DNA polymerases.
    Type: Grant
    Filed: May 20, 2014
    Date of Patent: August 30, 2016
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Keith Bauer, Thomas W. Myers, Shawn Suko
  • Patent number: 9428783
    Abstract: The present invention describes novel bacterial L-amino acids ?-ligases, which catalyzing reaction of dipeptide formation having an acidic L-amino acid such as L-Asp or L-Glu at the N-terminus. The method for producing dipeptides using said L-amino acids ?-ligases and a bacterium of the family Enterobacteriaceae, particularly a bacterium belonging to the genus Escherichia, which has been modified to contain the DNA encoding said L-amino acids ?-ligases, is described.
    Type: Grant
    Filed: January 7, 2015
    Date of Patent: August 30, 2016
    Assignee: Ajinomoto Co., Inc.
    Inventors: Sergey Vasilievich Smirnov, Pavel Mikhailovich Sokolov, Takayuki Ito
  • Patent number: 9428784
    Abstract: Methods for increasing the yield and N-glycosylation site occupancy of paucimannose or complex N-glycans of recombinant glycoproteins produced in a recombinant host cell lacking dolichyl-P-Man:Man5GlcNAc2-PP-dolichyl alpha-1,3 mannosyltransferase (Alg3p) activity are disclosed. In particular, recombinant host cells are provided that comprise a disruption of the expression of an OS-9 family gene in the host cell. These recombinant host cells may then be used for producing recombinant glycoproteins. In further embodiments, the recombinant host cells further overexpress at least one heterologous single-subunit oligosaccharyltransferase, which in particular embodiments is capable of functionally suppressing the lethal phenotype of a mutation of at least one essential protein of the yeast oligosaccharyltransferase (OTase) complex.
    Type: Grant
    Filed: October 23, 2012
    Date of Patent: August 30, 2016
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Byung-Kwon Choi, Stephen R. Hamilton, Natarajan Sethuraman
  • Patent number: 9428785
    Abstract: Embodiments of the invention include analyte-responsive compositions and electrochemical analyte sensors having a sensing layer that includes an analyte-responsive enzyme and a cationic polymer. Also provided are systems and methods of making the sensors and using the electrochemical analyte sensors in analyte monitoring.
    Type: Grant
    Filed: December 2, 2014
    Date of Patent: August 30, 2016
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Tianmei Ouyang, Zenghe Liu
  • Patent number: 9428786
    Abstract: A biological sterilization indicator (BI) system and method. The system can include a BI and a reading apparatus comprising a well. The BI can include a housing, which can include a first portion, and a second portion movable between a first “unactivated” position and a second “activated” position. The BI can further include a frangible container containing a liquid and dimensioned to be positioned in the housing. The reading apparatus can be configured to detect activation of the biological sterilization indicator, for example, by detecting that the second portion is in the second position, and/or by detecting that the liquid from the frangible container is present in a specific chamber of the biological sterilization indicator. The method can include positioning the BI in the well of the reading apparatus and detecting activation, for example, by detecting one or more of the above conditions.
    Type: Grant
    Filed: August 18, 2015
    Date of Patent: August 30, 2016
    Inventors: Jeffrey C. Pederson, Sailaja Chandrapati, Bryan S. Behun, Barry W. Robole, Leroy J. Longworth
  • Patent number: 9428787
    Abstract: An apparatus and an assembly for processing a sample are provided. The apparatus comprises a plurality of spaced-apart reservoirs, a plurality of channels, and a plurality of outlets, each outlet comprising an effluent discharge opening. The apparatus forms a plurality of flow paths, each flow path comprising a reservoir, a channel, and an outlet. An analyte capture element can be slideably engaged in a channel in a position where it is in fluid communication with the flow path. The apparatus with the analyte capture element disposed in the flow path can be used to process a liquid sample. A method of detecting an analyte in the liquid sample is also provided.
    Type: Grant
    Filed: May 24, 2013
    Date of Patent: August 30, 2016
    Assignee: 3M Innovative Properties Company
    Inventors: Jon A. Kirschhoffer, Andrew H. Tilstra, Wensheng Xia
  • Patent number: 9428788
    Abstract: A method for transferring a quantity of analytes comprising at least stages of: predisposing a substantially homogeneous mixture of a predetermined initial quantity of at least an analyte and a liquid, obtaining a known concentration value or known amount of the analyte in the mixture; introducing into the mixture at least a collecting portion (3) of a sampling device (1) having a support body (2), the collecting portion (3) comprising a plurality of fibers (6) attached to and arranged on a first portion (2a) of the support body (2) by means of flocking, in order to define a flocked collecting portion (3) or a flocked tampon, such as to collect a part of the mixture on the collecting portion (3); and extracting the collecting portion (3) of the sampling device (1) of the mixture, retaining on the sampling portion (3) a predetermined known quantity of the mixture to be transferred.
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: August 30, 2016
    Assignee: COPAN Italia S.p.A.
    Inventor: Daniele Triva
  • Patent number: 9428789
    Abstract: A method is disclosed for classifying and distinguishing between type I and type II kinase inhibitors. The method involves the use of non-linear optical techniques, in particular second-harmonic generation (SHG) to identify conformational changes in kinase proteins obtained from known type I or type II inhibitors. The method further involves deducing the manner of binding of unknown inhibitors by comparison with the signal changes produced by known ligands. The method is also applied to comparing the conformational changes induced by the binding of generic and branded kinase inhibitor drugs to a target kinase.
    Type: Grant
    Filed: March 21, 2012
    Date of Patent: August 30, 2016
    Assignee: BIODESY, INC.
    Inventors: Joshua S. Salafsky, Ryan McGuinness
  • Patent number: 9428790
    Abstract: A method for the simultaneous measurement of proteolylic enzyme generation and clot strength in plasma or whole blood or any appropriate biological sample derived from blood. The measurement method encompasses the use of a detectable substrate which includes a moiety that can be released upon reaction with the targeted proteolytic enzyme, and elements for measurement of an increase in viscosity of clot strength.
    Type: Grant
    Filed: June 20, 2013
    Date of Patent: August 30, 2016
    Assignee: SYNAPSE B.V.
    Inventors: Bas H. De Laat, Hendrik Coenraad Hemker, Leonie Pelkmans, Hilde Kelchtermans
  • Patent number: 9428791
    Abstract: Methods for obtaining structural data from RNA in a sample, and RNA probes for performing the same, are provided. Methods of reversibly modifying RNA is a sample, in vitro or in vivo, and reversible probes for performing the same, are provided. The RNA probes may be SHAPE probes that include aryl or heteroaryl acyl imidazoles. The RNA probes may be reversible probes that include an aryl or heteroaryl ring substituted with a hydroxyl-reactive group and an azido-containing group. Also provided are methods of comparing in vitro and in vivo RNA structural data. Also provided are methods of diagnosing a cellular proliferative disease condition, e.g., by probing HOTAIR RNA. Aspects of the invention further include compositions, e.g., probes and kits, etc., that find use in methods of the invention.
    Type: Grant
    Filed: August 14, 2013
    Date of Patent: August 30, 2016
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Robert Carl Spitale, Peter Joseph Crisalli, Howard Yuan-Hao Chang, Eric Todd Kool, Jong Hwa Jung
  • Patent number: 9428792
    Abstract: The present disclosure relates to nucleic-acid based product authentication and identification by determining authentication codes comprising target nucleic acids using oligonucleotide probes associated with samples. The presence of the authentication code is determined using detection methods, such as flow cytometric methods, capable of particle discrimination based on the light scattering or fluorescence properties of the particle. Target-correlated fluorescence signal, originating from a target nucleic acid hybridized to labeled complementary oligonucleotides is determined as an indicator of the presence of the authentication code. In some embodiments, an intercalating dye is used to determine the presence of target nucleotide/oligonucleotide heterodimers and identify an authentication code.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: August 30, 2016
    Assignee: CertiRx Corporation
    Inventors: Thomas J. Mercolino, Amy McPherson, James Garber Rudulph, Jr.
  • Patent number: 9428793
    Abstract: Methods, devices and systems for performing digital measurements are provided.
    Type: Grant
    Filed: January 20, 2012
    Date of Patent: August 30, 2016
    Assignee: University of Washington Through Its Center For Commercialization
    Inventors: Daniel T. Chiu, Bryant S. Fujimoto, Alexander R. Gansen, Gloria S. Yen, Robert M. Lorenz
  • Patent number: 9428794
    Abstract: Provided are methods of depleting a target nucleic acid in a sample. The methods include contacting a target nucleic acid with two or more polymers that specifically hybridize to the target nucleic acid, and cleaving the hybridized regions of the target nucleic acid to deplete the target nucleic acid in the sample. Kits for practicing the subject methods are also provided.
    Type: Grant
    Filed: September 10, 2013
    Date of Patent: August 30, 2016
    Assignee: Takara Bio USA, Inc.
    Inventors: Andrew Farmer, Ian Oglesby, Magnolia Bostick, Steve Oh
  • Patent number: 9428795
    Abstract: To provide a means and a method of quickly sampling a tissue fragment from a plant tissue, quickly preserving a gene expression state within the tissue fragment, and comprehensively analyzing the gene expression state. The present invention relates to a method of sampling a plant tissue section, comprising: inserting a first gel layer into a needle; arranging a plant tissue on a second gel layer; and passing the needle through the plant tissue together with the second gel layer, and sampling a section of the plant tissue in the needle.
    Type: Grant
    Filed: December 18, 2012
    Date of Patent: August 30, 2016
    Assignee: Hitachi, Ltd.
    Inventors: Tomoharu Kajiyama, Hideki Kambara, Toru Habu
  • Patent number: 9428796
    Abstract: The present invention provides a method for indirectly and with high sensitivity detecting a particle dispersed and moving randomly in a solution using a luminescent probe.
    Type: Grant
    Filed: July 2, 2014
    Date of Patent: August 30, 2016
    Assignee: OLYMPUS CORPORATION
    Inventor: Hidetaka Nakata
  • Patent number: 9428797
    Abstract: This invention provides novel compositions and processes for analyte detection, quantification and amplification. Nucleic acid arrays and libraries of analytes are usefully incorporated into such compositions and processes. Universal detection elements, signaling entities and the like are employed to detect and if necessary or desirable, to quantify analytes. Amplification of target analytes are also provided by the compositions and processes of this invention.
    Type: Grant
    Filed: July 29, 2004
    Date of Patent: August 30, 2016
    Assignee: Enzo Life Sciences, Inc.
    Inventors: Elazar Rabbani, Jannis G. Stavrianopoulos, James J. Donegan, Jack Coleman
  • Patent number: 9428798
    Abstract: A polynucleotide comprising a first region the 5? end of which is complementary to a portion of a target nucleic acid, a cleavable second region, a third region having a stem-loop structure, and a fourth region complementary to the 3? end of the first region, and use of the polynucleotide, as well as a composition comprising two such polynucleotides each of which hybridize different strands of a double-stranded target nucleic acid, and methods and kits using the same for amplifying targets.
    Type: Grant
    Filed: May 9, 2014
    Date of Patent: August 30, 2016
    Assignee: SAMSUNG ELECTRONICS CO., LTD
    Inventors: Sea-hee Kim, Joon-ho Kim, Joo-won Rhee, Sun-ok Jung, Ko-bong Choi, Kyu-youn Hwang
  • Patent number: 9428799
    Abstract: A method of identifying alleles of polymorphic sites in a plurality of nucleic acid samples including the steps of determining a source tag sharing number “d” for each of the alleles; performing a first reaction in a plurality of pools of the alleles to be identified to produce reaction products including a source tag identifying said each pool; pooling the pools to provide pooled pools; for each of the alleles to be identified, performing a second reaction using said reaction products to produce allele-specific second reaction products comprising a marker tag and a derived source tag; identifying said allele-specific second reaction products to identify the alleles. If “d” is equal to or larger than a maximum pool size, the first reaction may not be performed. Alleles may be binned together. A microparticle comprising one or more capture probes each comprising an oligonucleotide complementary to a subsequence of a target polynucleotide.
    Type: Grant
    Filed: July 25, 2011
    Date of Patent: August 30, 2016
    Assignee: Bioinventors & Entrepreneurs Network LLC
    Inventor: Michael Seul
  • Patent number: 9428800
    Abstract: A system for holding at least one of sample and reagent for analysis. The system includes a pair of parallel covers, at least one of which is light transmissive, of which pair a light transmissive cover forms a top, and of which pair the other forms a bottom. A frame is disposed between the covers to define, in relation to the covers, an interior volume. The frame and the covers are associated with one another to form a case, the case being substantially tight to liquids. A microfluidic array is disposed in the interior volume. The array includes a sheet of material having a pair of opposed surfaces, a thickness, and a plurality of through-holes running through the thickness between the surfaces, the through-holes containing at least one of sample and reagent.
    Type: Grant
    Filed: March 3, 2014
    Date of Patent: August 30, 2016
    Assignee: Life Technologies Corporation
    Inventors: John Linton, Arrin Katz, Colin Brenan, Karl Yoder, Robert Hess, Leila Madrone, Robert Ellis, Tanya Kanigan, Kristine Friesen, Thomas Morrison, Javier Garcia
  • Patent number: 9428801
    Abstract: The present invention provides compositions and methods for rapidly amplifying target nucleic acid (e.g., using whole genome amplification) that allows small amounts of starting nucleic acid to be employed. In certain embodiments, the methods employ compositions that comprise: phi29 polymerase, exo- Klenow polymerase and/or Klenow polymerase, dNTPs, primers, and a buffering agent. In some embodiments, the target nucleic acid is amplified at a rate that would result in at least 1000-fold amplification in thirty minutes.
    Type: Grant
    Filed: December 29, 2011
    Date of Patent: August 30, 2016
    Assignee: IBIS BIOSCIENCES, INC.
    Inventors: Mark Eshoo, Stanley Motley, John Picuri
  • Patent number: 9428802
    Abstract: Disclosed herein is a self-competitive primer for preferentially amplifying a sample nucleic acid based on whether a selected region thereof has a nucleotide variation, in comparison with a selected region of a reference nucleic acid. The self-competitive primer includes a 5?-competing domain and a 3?-elongating domain. Sequences of the 5?-competing domain and the 3?-elongating domain are complementary to a first region and a second region of the reference nucleic acid, respectively. The first region includes the selected region and at least one nucleotide residue immediately downstream of the selected region of the reference nucleic acid. The second region is located downstream of the selected region of the reference nucleic acid and does not comprise the selected region of the reference nucleic acid, and the first region and the second region overlap by at least one nucleotide.
    Type: Grant
    Filed: July 3, 2012
    Date of Patent: August 30, 2016
    Assignee: MACKAY MEMORIAL HOSPITAL
    Inventors: Jr-kai Huang, Chi-Kuan Chen, Tao-Yeuan Wang
  • Patent number: 9428803
    Abstract: A mechanism is provided for ratcheting a double strand molecule. The double strand molecule is driven into a Y-channel of a membrane by a first voltage pulse. The Y-channel includes a stem and branches, and the branches are connected to the stem at a junction. The double strand molecule is slowed at the junction of the Y-channel based on the first voltage pulse being weaker than a force required to break a base pair of the double strand molecule. The double strand molecule is split into a first single strand and a second single strand by driving the double strand molecule into the junction of the Y-channel at a second voltage pulse.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: August 30, 2016
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Binquan Luan, Ruhong Zhou
  • Patent number: 9428804
    Abstract: A mechanism is provided for ratcheting a double strand molecule. The double strand molecule is driven into a Y-channel of a membrane by a first voltage pulse. The Y-channel includes a stem and branches, and the branches are connected to the stem at a junction. The double strand molecule is slowed at the junction of the Y-channel based on the first voltage pulse being weaker than a force required to break a base pair of the double strand molecule. The double strand molecule is split into a first single strand and a second single strand by driving the double strand molecule into the junction of the Y-channel at a second voltage pulse.
    Type: Grant
    Filed: August 20, 2013
    Date of Patent: August 30, 2016
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Binquan Luan, Ruhong Zhou
  • Patent number: 9428805
    Abstract: A technique is provided for forming a nanodevice for sequencing. A bottom metal contact is disposed at a location in an insulator that is on a substrate. A nonconducting material is disposed on top of the bottom metal contact and the insulator. A carbon nanotube is disposed on top of the nonconducting material. Top metal contacts are disposed on top of the carbon nanotube at the location of the bottom metal contact, where the top metal contacts are formed at opposing ends of the carbon nanotube at the location. The carbon nanotube is suspended over the bottom metal contact at the location, by etching away the nonconducting material under the carbon nanotube to expose the bottom metal contact as a bottom of a trench, while leaving the nonconducting material immediately under the top metal contacts as walls of the trench.
    Type: Grant
    Filed: September 26, 2013
    Date of Patent: August 30, 2016
    Assignee: GLOBALFOUNDRIES Inc.
    Inventors: Ali Afzali-Ardakani, Aaron D. Franklin, George S. Tulevski
  • Patent number: 9428806
    Abstract: Systems and methods for specific nucleic acid (NA) sequence detection that do not rely on polymerase chain reaction (PCR) for target sequence amplification and do not require any special reagents other than a complementary sequence capture probe conjugated to spherical beads.
    Type: Grant
    Filed: February 25, 2014
    Date of Patent: August 30, 2016
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Harold G. Monbouquette, Jacob J. Schmidt
  • Patent number: 9428807
    Abstract: A method for nucleic acid sequencing includes disposing template polynucleotide strands in defined spaces on a sensor array, at least some of the template polynucleotide strands having a sequencing primer and a polymerase operably bound therewith; exposing the template polynucleotide strands to a series of flows of nucleotide species flowed according to a predetermined ordering; and determining, for each of the series of flows of nucleotide species, how many nucleotide incorporations occurred for that particular flow to determine a predicted sequence of nucleotides corresponding to the template polynucleotide strands, wherein the predetermined ordering (a) is not a series of consecutive repetitions of a 4-flow permutation of four different nucleotide species, (b) is not specifically tailored to a particular combination of a particular template polynucleotide strand to be sequenced and a particular sequencing primer to be used, and (c) comprises a phase-protecting flow ordering.
    Type: Grant
    Filed: April 5, 2012
    Date of Patent: August 30, 2016
    Assignee: LIFE TECHNOLOGIES CORPORATION
    Inventors: Earl Hubbell, Jonathan Schultz
  • Patent number: 9428808
    Abstract: This invention provides markers, methods, biochips and kits for milk quality detection. The present invention particularly provides a method for milk quality detection by means of detecting the particular microRNAs in milk, so as to establish the standard of raw milk content.
    Type: Grant
    Filed: May 27, 2010
    Date of Patent: August 30, 2016
    Assignee: JIANGSU MICROMEDMARK BIOTECH CO., LTD.
    Inventors: Chengyu Zhang, Ke Zeng, Junfeng Zhang, Chunliang Tian, Haijin Li
  • Patent number: 9428809
    Abstract: Provided are a solid-phase carrier for solid-phase synthesis of nucleic acid having improved amino group reactivity, and an aminated oligonucleotide to which an amino group has been attached. The present invention relates to an aminated oligonucleotide represented by formula (I).
    Type: Grant
    Filed: July 31, 2012
    Date of Patent: August 30, 2016
    Assignee: National Institute of Advanced Industrial Science and Technology
    Inventors: Yasuo Komatsu, Naoshi Kojima
  • Patent number: 9428810
    Abstract: This invention relates to methods, articles and compositions useful in detecting target substances in an alcoholic preservative solution, and for identifying sensors useful for binding to such targets. The methods allow for the simultaneous performance of sufficient fixation of a sample and binding of a detectable sensor to a target of interest in the sample. In one aspect, a method is provided that comprises contacting a sample suspected of containing a target with a detectable sensor molecule known to bind to such target in an alcoholic preservative solution. The method maybe performed in multiplex form to permit simultaneous analysis of a plurality of targets. Methods for identifying a sensor capable of binding to a desired target in an alcoholic preservative solution are also provided. An alcoholic preservative solution comprising one or more such detectable sensors is also provided. Also provided is a sample comprising a bound sensor provided by such a process.
    Type: Grant
    Filed: March 20, 2009
    Date of Patent: August 30, 2016
    Assignee: Hologic, Inc.
    Inventors: James Linder, Menashi Cohenford, Erin Coffman, Brian B. Lentrichia, Henrik Stender, Kenneth Oliveira
  • Patent number: 9428811
    Abstract: Provided herein are methods of characterizing the epigenetic signature of human induced pluripotent stem cells. The methods are useful in identifying human induced pluripotent stem cells (hiPSCs), diagnostic markers for incomplete hiPSCs reprogramming, and characterization of the efficacy of different reprogramming techniques.
    Type: Grant
    Filed: April 29, 2013
    Date of Patent: August 30, 2016
    Assignee: Salk Institute for Biological Studies
    Inventors: Ronald M. Evans, Joseph R. Ecker, Ryan Lister
  • Patent number: 9428812
    Abstract: Disclosed are methods and kits for detecting the presence of a cancer in a subject and assessing the efficacy of treatments for the same. The disclosed method use reverse transcription polymerase chain reaction (RT-PCR) techniques to detect the presence of point mutations, truncations, or fusions of anaplastic lymphoma kinase.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: August 30, 2016
    Assignee: Insight Genetics, Inc.
    Inventors: David R. Hout, Rachel Skelton, John Handshoe, Kasey Lawrence, Brock Schweitzer